DNMT1 and cancer: As DNA hypermethylation has been linked to cancer progression, clinical studies have focused on inhibitors of DNA methyltransferases (DNMT) as a potential therapeutic approach to reverse this cancer-promoting epigenetic change (Figure 1) [21,22].